Drugs / Vital NAD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06036355 | Sep 2023 → Apr 2024 | — | Shanghai Cell Therapy Group Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vital NAD | “NMN (Vital NAD) 600mg/day for at least 50 days” NCT06036355 ↗ |
| Known as | NMN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06036355 ↗ |